By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > Potassium-sparing diuretic > Spironolactone

Spironolactone

GMJ
Last updated: 02/06/2026 14:31
By
Prof. Giorgi Pkhakadze
Share
4 Min Read
SHARE
3 min read|574 words

What is Spironolactone?

Spironolactone is a potassium-sparing diuretic that works by blocking aldosterone receptors in the kidneys. It is primarily used to treat fluid retention, high blood pressure, and certain hormonal conditions. Unlike other diuretics, spironolactone helps the body eliminate excess sodium and water while retaining potassium.

Uses

Spironolactone has several approved medical uses:

  • Heart failure: Used as an add-on treatment to reduce fluid buildup and improve survival rates in patients with severe heart failure
  • High blood pressure: Helps lower blood pressure by reducing fluid volume and blocking aldosterone effects on blood vessels
  • Edema: Treats fluid retention associated with liver disease, kidney disorders, or congestive heart failure
  • Primary aldosteronism: Manages conditions where the body produces too much aldosterone hormone
  • Hirsutism and acne: Used off-label in women to treat excess hair growth and hormonal acne by blocking androgen receptors

How it works

Spironolactone blocks aldosterone receptors in the distal tubules of the kidneys, preventing sodium reabsorption and potassium loss. This mechanism causes the body to excrete excess sodium and water through urine while conserving potassium. The drug also has anti-androgen properties, which explains its effectiveness in treating certain hormonal conditions in women.

Side effects

Common side effects include:

Submit Your Paper
GMJ_Submit_Banner
  • Elevated potassium levels (hyperkalemia)
  • Dizziness or lightheadedness
  • Headache
  • Nausea and vomiting
  • Diarrhea
  • Drowsiness or fatigue
  • Irregular menstrual periods in women
  • Breast tenderness or enlargement

Serious side effects requiring immediate medical attention:

  • Severe hyperkalemia (muscle weakness, irregular heartbeat)
  • Signs of electrolyte imbalance (confusion, muscle cramps, severe weakness)
  • Kidney problems (decreased urination, swelling)
  • Severe allergic reactions (rash, difficulty breathing, swelling of face or throat)
  • Liver problems (yellowing of skin or eyes, dark urine)

Warnings and precautions

  • Kidney disease: Patients with severe kidney impairment should avoid spironolactone due to increased risk of dangerous potassium buildup
  • Hyperkalemia risk: Regular monitoring of potassium levels is essential, especially when starting treatment or adjusting doses
  • Pregnancy: Generally avoided during pregnancy due to potential hormonal effects on fetal development; classified as pregnancy category C
  • Addison’s disease: Contraindicated in patients with this condition due to already elevated potassium levels
  • Elderly patients: Require closer monitoring due to increased sensitivity to electrolyte changes and higher risk of kidney problems

Interactions

Spironolactone has several important drug interactions:

  • ACE inhibitors and ARBs: Increase risk of hyperkalemia when combined with spironolactone
  • Potassium supplements: Can lead to dangerous potassium levels and should generally be avoided
  • NSAIDs: May reduce spironolactone’s effectiveness and increase kidney damage risk
  • Lithium: Spironolactone can increase lithium levels, potentially causing toxicity
  • Digoxin: May increase digoxin levels and risk of side effects
  • Salt substitutes: Many contain potassium and can contribute to hyperkalemia
  • Trimethoprim-sulfamethoxazole: Increases potassium retention risk
  • Heparin: Long-term use with spironolactone may increase potassium levels

Check interactions with the GMJ Interaction Checker

Dosage

Typical adult dosages vary by condition:

  • Heart failure: Usually 25-50 mg once daily, may be increased to 25 mg twice daily
  • High blood pressure: 50-100 mg daily, given as single dose or divided doses
  • Edema: 25-200 mg daily, depending on response and underlying condition
  • Primary aldosteronism: 100-400 mg daily for diagnosis; 100-400 mg daily for long-term management

Dosages should always be individualized and determined by a healthcare provider based on the patient’s specific condition, kidney function, and response to treatment. Regular monitoring of electrolytes and kidney function is essential during treatment.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Spironolactone." GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/drug/spironolactone/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Related topics

Optional further reading from the GMJ knowledge base.

In the news
Kidney Drug Finerenone Shows Promise for Non-Diabetic Chronic Kidney Disease
In the news
  • Kidney Drug Finerenone Shows Promise for Non-Diabetic Chronic Kidney Disease · Jun 24, 2026
Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
How amino acids shape brain function: neurotransmitters, energy, and cognitive resilience

Amino acids are the precursors to neurotransmitters and metabolic substrates for brain…

How Coffee and Tea Reduce Iron Absorption: A Mechanism Explained

Polyphenols in coffee and tea bind non-heme iron in the gut, reducing…

Eggs and Alzheimer’s risk: New evidence from a 15-year study challenges decades of dietary caution

A 15-year study of 39,498 older adults found that eating eggs five…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Amiloride

By
Prof. Giorgi Pkhakadze
02/06/2026

Eplerenone

By
Prof. Giorgi Pkhakadze
02/06/2026

Triamterene

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up